NFKB1 and cancer: In animal and cellular experiments, EGCG dose-dependently downregulated the mRNA levels and protein expression levels of NF-κB and matrix metalloproteinase-9 in bladder cancer cells, and inhibited the cancer cell proliferation and migration in nude mice [84].